Literature DB >> 9834205

Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders.

K Döhner1, J Brown, U Hehmann, C Hetzel, J Stewart, G Lowther, C Scholl, S Fröhling, A Cuneo, L C Tsui, P Lichter, S W Scherer, H Döhner.   

Abstract

Loss of chromosome 7 (-7) or deletion of the long arm (7q-) are recurring chromosome abnormalities in myeloid leukemias. The association of -7/7q- with myeloid leukemia suggests that these regions contain novel tumor suppressor gene(s), whose loss of function contribute to leukemic transformation or tumor progression. Based on chromosome banding analysis, two critical regions have been identified, one in band q22 and another in bands q32-q35. Presently there are no data available on the molecular delineation of the distal critical region. In this study we analyzed bone marrow and blood samples from 13 patients with myeloid leukemia (de novo myelodysplastic syndrome [MDS], n = 3; de novo acute myeloid leukemia [AML], n = 9; therapy-related (t-) AML, n = 1) which, on chromosome banding analysis, exhibited deletions (n = 12) or in one case a balanced translocation involving bands 7q31-qter using fluorescence in situ hybridization (FISH). As probes we used representative clones from a contig map of yeast artificial chromosome (YAC) clones that spans chromosome bands 7q31.1-qter. In the 12 cases with loss of 7q material, we identified a commonly deleted region of approximately 4 to 5 megabasepairs in size encompassing the distal part of 7q35 and the proximal part of 7q36. Furthermore, the breakpoint of the reciprocal translocation from the patient with t-AML was localized to a 1,300-kb sized YAC clone that maps to the proximal boundary of the commonly deleted region. Interestingly, in this case both homologs of chromosome 7 were affected: one was lost (-7) and the second exhibited the t(7q35). The identification and delineation of translocation and deletion breakpoints provides the first step toward the identification of the gene(s) involved in the pathogenesis of 7q35-q36 aberrations in myeloid disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834205

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  In vivo interference with Skp1 function leads to genetic instability and neoplastic transformation.

Authors:  Roberto Piva; Jian Liu; Roberto Chiarle; Antonello Podda; Michele Pagano; Giorgio Inghirami
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

2.  Cloning of B cell lymphoma-associated antigens using modified phage-displayed expression cDNA library and immunized patient sera.

Authors:  Soung-Chul Cha; Larry W Kwak; Pier Adelchi Ruffini; Hong Qin; Sattva Neelapu; Arya Biragyn
Journal:  J Immunol Methods       Date:  2006-03-31       Impact factor: 2.303

Review 3.  Histone-modifying enzymes: regulators of developmental decisions and drivers of human disease.

Authors:  Jill S Butler; Evangelia Koutelou; Andria C Schibler; Sharon Y R Dent
Journal:  Epigenomics       Date:  2012-04       Impact factor: 4.778

4.  Genome-wide genotyping of acute myeloid leukemia with translocation t(9;11)(p22;q23) reveals novel recurrent genomic alterations.

Authors:  Michael W M Kühn; Lars Bullinger; Stefan Gröschel; Jan Krönke; Jennifer Edelmann; Frank G Rücker; Karina Eiwen; Peter Paschka; Verena I Gaidzik; Karlheinz Holzmann; Richard F Schlenk; Hartmut Döhner; Konstanze Döhner
Journal:  Haematologica       Date:  2014-05-23       Impact factor: 9.941

5.  Human eIF4AIII interacts with an eIF4G-like partner, NOM1, revealing an evolutionarily conserved function outside the exon junction complex.

Authors:  Andrei Alexandrov; David Colognori; Joan A Steitz
Journal:  Genes Dev       Date:  2011-05-15       Impact factor: 11.361

Review 6.  Therapy-related myeloid neoplasms: when genetics and environment collide.

Authors:  Megan E McNerney; Lucy A Godley; Michelle M Le Beau
Journal:  Nat Rev Cancer       Date:  2017-08-24       Impact factor: 60.716

7.  Human DMTF1β antagonizes DMTF1α regulation of the p14(ARF) tumor suppressor and promotes cellular proliferation.

Authors:  Mario P Tschan; Elena A Federzoni; Aladin Haimovici; Christian Britschgi; Bettina A Moser; Jing Jin; Venkateshwar A Reddy; Dennis A Sheeter; Kimberlee M Fischer; Peiqing Sun; Bruce E Torbett
Journal:  Biochim Biophys Acta       Date:  2015-07-15

8.  Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells.

Authors:  Melisa Ruiz-Gutierrez; Özge Vargel Bölükbaşı; Gabriela Alexe; Adriana G Kotini; Kaitlyn Ballotti; Cailin E Joyce; David W Russell; Kimberly Stegmaier; Kasiani Myers; Carl D Novina; Eirini P Papapetrou; Akiko Shimamura
Journal:  JCI Insight       Date:  2019-04-30

Review 9.  Unraveling the molecular pathophysiology of myelodysplastic syndromes.

Authors:  Rafael Bejar; Ross Levine; Benjamin L Ebert
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

10.  Identification of two critically deleted regions within chromosome segment 7q35-q36 in EVI1 deregulated myeloid leukemia cell lines.

Authors:  An De Weer; Bruce Poppe; Sarah Vergult; Pieter Van Vlierberghe; Marjan Petrick; Robrecht De Bock; Yves Benoit; Lucien Noens; Anne De Paepe; Nadine Van Roy; Björn Menten; Frank Speleman
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.